Int J Mol Med 43: 1331--1342, 2019; DOI: 10.3892/ijmm.2019.4077

Owing to oversights during the production process, a pair of errors were introduced into the above article. First, in the Materials and methods section, *Animals and cell lines* subsection, on p. 1332, line 12, the sentence starting here should have read as: \'The non-tumorigenic mouse hepatocyte **alpha mouse liver 12 (AML12)** cell line was purchased from the Shanghai Cell Bank of Chinese Academy of Sciences (Shanghai, China)\' (i.e., the abbreviation AML12 was expanded incorrectly). Secondly, the bottom row of data was accidentally omitted from Table I (pertaining to the Suzuki score for liver ischemia/reperfusion injury assessed to be severe).The fifth data row in the Table should have read, from left to right, as follows: Numerical assessment, \'4\'; Congestion, \'Severe (\>60%)\'; Vacuolization, \'Severe (\>60%)\'; and Necrosis, \'Severe (\>60%)\'.

We regret that these errors were introduced into the published version of this paper, and apologize to the authors and the readership for the inconvenience caused.
